LI-MIN HUANGSchibler, AndreasAndreasSchiblerHuang, Yi-ChuanYi-ChuanHuangTai, AndrewAndrewTaiChi, HsinHsinChiChieng, Chae-HeeChae-HeeChiengWang, Jinn-LiJinn-LiWangGoldbart, AvivAvivGoldbartTang, Swee-PingSwee-PingTangHuang, Yhu-CheringYhu-CheringHuangGeorge, ShaneShaneGeorgeAlabaz, DeryaDeryaAlabazBentur, LeaLeaBenturSu, Siew-ChooSiew-ChooSude Bruyne, JessieJessiede BruyneKaradag, BulentBulentKaradagGu, FengFengGuZou, GangGangZouToovey, StephenStephenTooveyDeVincenzo, John PJohn PDeVincenzoWu, Jim ZJim ZWu2023-11-232023-11-232023-0717502640https://scholars.lib.ntu.edu.tw/handle/123456789/637314Respiratory syncytial virus (RSV) infection is a cause of substantial morbidity and mortality in young children. There is currently no effective therapy available.enAK0529; fusion inhibitor; infants; respiratory syncytial virus (RSV); ziresovir[SDGs]SDG3Safety and efficacy of AK0529 in respiratory syncytial virus-infected infant patients: A phase 2 proof-of-concept trialjournal article10.1111/irv.13176375026222-s2.0-85165894114https://api.elsevier.com/content/abstract/scopus_id/85165894114